These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27135108)

  • 21. [Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].
    Fedulenkova LV
    Eksp Klin Gastroenterol; 2009; (5):130-7. PubMed ID: 20201315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging therapies for portal hypertension in cirrhosis.
    Nair H; Berzigotti A; Bosch J
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):167-81. PubMed ID: 27148904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational hemodynamics of portal vein hypertension in hepatic cirrhosis patients.
    Li X; Wang XK; Chen B; Pu YS; Li ZF; Nie P; Su K
    Biomed Mater Eng; 2015; 26 Suppl 1():S233-43. PubMed ID: 26406008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiologic basis for the medical management of portal hypertension.
    Poordad FF; Sigal SH; Brown RS
    Expert Opin Pharmacother; 2009 Feb; 10(3):453-67. PubMed ID: 19191681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
    Merkel C; Montagnese S
    Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Portal hypertensive gastropathy in cirrhosis].
    Møller S; Becker PU; Henriksen JH
    Ugeskr Laeger; 1993 May; 155(19):1480-1. PubMed ID: 8316979
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breaking bad - the two sides of gut microbiota in portal hypertension.
    Mehta G; Mookerjee RP
    Liver Int; 2014 Oct; 34(9):1295-7. PubMed ID: 24840789
    [No Abstract]   [Full Text] [Related]  

  • 31. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of Salvia miltiorrhizae and Astragalus membranaceus on hemodynamics and liver fibrosis indexes in liver cirrhotic patients with portal hypertension].
    Tan YW; Yin YM; Yu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 May; 21(5):351-3. PubMed ID: 12577420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological therapy of portal hypertension--focused on Korean data].
    Baik SK
    Korean J Gastroenterol; 2005 Jun; 45(6):381-6. PubMed ID: 15973071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 37. [Doppler blood flow measurements in the portal system].
    Kalina Z; Scieszka J; Maślankiewicz A
    Pol Przegl Radiol; 1988; 52(6):284-6. PubMed ID: 3077452
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of endoscopy in primary prophylaxis for esophageal variceal bleeding.
    Albillos A; Peñas B; Zamora J
    Clin Liver Dis; 2010 May; 14(2):231-50. PubMed ID: 20682232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological modulation of portal hypertension syndrome: current status and future prospects].
    González García M; Albillos Martínez A
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():1-7. PubMed ID: 15195528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.